-
Dr Anastasios Tentolouris
GLP-1 therapy and cardiorenal outcomes in type 1 diabetes: a propensity-matched real-world analysis
-
Professor Laurent Castera
Screening and non-invasive detection of MASLD, MASH and liver fibrosis.
-
Dr Arya Sharma
What Is Metabolically Healthy Obesity?
-
Professor Laurent Castera
Management of MASLD and MASH, including liver fibrosis assessment and treatment pathways.
-
Dr Arya Sharma
When to Treat Metabolically Healthy Obesity
